The FGF21, a hormone that reduces the levels of glucose, is also an activator of brown adipose tissue metabolism, according to research that is cover of the latest issue of the journal Cell Metabolism, And Francesc Villarroya directing the Department of Biochemistry and Molecular Biology, University of Barcelona (UB) and CIBER Physiopathology of Obesity and Nutrition.
The study, published in the journal Cell MetabolismHas been done on mice neonates and could open new therapeutic targets to combat obesity by fibroblast growth factor 21 (FGF21), which releases the liver in response to dietary lipids.
In the article, the team describes how a new scoop on the action of FGF21 brown adipose tissue, the manager of energy expenditure and body heat generation.
“The FGF21 is an antidiabetic and antiobesity agent described in scientific literature since 2005,” says Villarroya.
Click to continue »
